pyranoprofen has been researched along with Dry Eye Syndromes in 4 studies
pyranoprofen: RN given refers to unlabled parent cpd; structure given in first source
Dry Eye Syndromes: Corneal and conjunctival dryness due to deficient tear production, predominantly in menopausal and post-menopausal women. Filamentary keratitis or erosion of the conjunctival and corneal epithelium may be caused by these disorders. Sensation of the presence of a foreign body in the eye and burning of the eyes may occur.
Excerpt | Relevance | Reference |
---|---|---|
"To investigate the clinical effect of sodium hyaluronate eye drops combined with tobramycin, dexamethasone, and pranoprofen eye drops in the treatment of dry eye after phacoemulsification." | 8.12 | Effect of sodium hyaluronate eye drops combined with tobramycin, dexamethasone and pranoprofen eye drops in the treatment of dry eye after phacoemulsification. ( Guan, Y; Lu, H; Nan, N; Su, Y; Yuan, Y, 2022) |
"To investigate the clinical effect of sodium hyaluronate eye drops combined with tobramycin, dexamethasone, and pranoprofen eye drops in the treatment of dry eye after phacoemulsification." | 4.12 | Effect of sodium hyaluronate eye drops combined with tobramycin, dexamethasone and pranoprofen eye drops in the treatment of dry eye after phacoemulsification. ( Guan, Y; Lu, H; Nan, N; Su, Y; Yuan, Y, 2022) |
"Dry eye is a multifactorial disease of the tears and the ocular surface." | 2.79 | Clinical efficacy of 0.1% pranoprofen in treatment of dry eye patients: a multicenter, randomized, controlled clinical trial. ( Chen, J; Chen, W; Deng, Y; Dong, F; Hong, J; Liu, Z; Sun, X; Xie, L; Yang, W; Zhang, M, 2014) |
"Sixty patients with dry eyes were randomized to 2 groups." | 2.77 | The effect of topical pranoprofen 0.1% on the clinical evaluation and conjunctival HLA-DR expression in dry eyes. ( Kao, AA; Liu, X; Long, Q; Wang, S, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Lu, H | 3 |
Guan, Y | 3 |
Su, Y | 3 |
Nan, N | 3 |
Yuan, Y | 3 |
Chen, J | 1 |
Dong, F | 1 |
Chen, W | 1 |
Sun, X | 1 |
Deng, Y | 1 |
Hong, J | 1 |
Zhang, M | 1 |
Yang, W | 1 |
Liu, Z | 1 |
Xie, L | 1 |
He, H | 2 |
Liu, ZG | 1 |
Lin, ZR | 1 |
Liu, XC | 1 |
Xiao, QG | 1 |
Liu, X | 1 |
Wang, S | 1 |
Kao, AA | 1 |
Long, Q | 1 |
2 trials available for pyranoprofen and Dry Eye Syndromes
Article | Year |
---|---|
Clinical efficacy of 0.1% pranoprofen in treatment of dry eye patients: a multicenter, randomized, controlled clinical trial.
Topics: Adult; Benzopyrans; Dry Eye Syndromes; Humans; Middle Aged; Ophthalmic Solutions; Propionates | 2014 |
The effect of topical pranoprofen 0.1% on the clinical evaluation and conjunctival HLA-DR expression in dry eyes.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents, Non-Steroidal; Benzopyrans; Conjunctiva; D | 2012 |
2 other studies available for pyranoprofen and Dry Eye Syndromes
Article | Year |
---|---|
Effect of sodium hyaluronate eye drops combined with tobramycin, dexamethasone and pranoprofen eye drops in the treatment of dry eye after phacoemulsification.
Topics: Dexamethasone; Dry Eye Syndromes; Humans; Hyaluronic Acid; Interleukin-6; Ophthalmic Solutions; Phac | 2022 |
Effect of sodium hyaluronate eye drops combined with tobramycin, dexamethasone and pranoprofen eye drops in the treatment of dry eye after phacoemulsification.
Topics: Dexamethasone; Dry Eye Syndromes; Humans; Hyaluronic Acid; Interleukin-6; Ophthalmic Solutions; Phac | 2022 |
Effect of sodium hyaluronate eye drops combined with tobramycin, dexamethasone and pranoprofen eye drops in the treatment of dry eye after phacoemulsification.
Topics: Dexamethasone; Dry Eye Syndromes; Humans; Hyaluronic Acid; Interleukin-6; Ophthalmic Solutions; Phac | 2022 |
Effect of sodium hyaluronate eye drops combined with tobramycin, dexamethasone and pranoprofen eye drops in the treatment of dry eye after phacoemulsification.
Topics: Dexamethasone; Dry Eye Syndromes; Humans; Hyaluronic Acid; Interleukin-6; Ophthalmic Solutions; Phac | 2022 |
[Therapeutic effects of Pyranoprofen on the mouse dry eye induced by topical medication of Benzalkonium Chloride].
Topics: Animals; Benzalkonium Compounds; Benzopyrans; Dry Eye Syndromes; Male; Mice; Mice, Inbred BALB C; Pr | 2012 |